Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease

Asako Yoritaka(Juntendo University), Nobutaka Hattori(RIKEN Center for Brain Science), Midori Nagase(Tokyo University of Technology), Toshiki Nakahara(Juntendo University), Kazuhiko Hashimoto(Online Technologies (United States)), Maya Ando(Juntendo University), Yorihiro Yamamoto(Tokyo University of Technology), Yufuko Saito(Higashi Nagoya National Hospital), Sumihiro Kawajiri(Fujimoto Dental and Oral Surgery Clinic)
Parkinsonism & Related Disorders
May 30, 2015
10.1016/j.parkreldis.2015.05.022
Cited by 93

Related Papers

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
|Nature|1998|5.2k
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
|Nature Genetics|2000|2k
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
|The Journal of Cell Biology|2010|1.9k
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
|Nature Genetics|2009|1.3k
Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease
|Science|2001|1.1k